BOSTON, Nov. 22, 2016 /PRNewswire/ -- Manna Molecular Science LLC ("MMS") of Boston, announces an exclusive licensing agreement with Temescal Wellness of Maryland ("Temescal") for the sale and wholesale distribution of transdermal patches in Maryland, bringing top pharmaceutical talent and experience to bear on therapeutic cannabis delivery systems.
Maryland is "a cornerstone of the Northeast corridor's cannabis marketplace," said MMS CEO Nial DeMena, adding "Temescal exemplifies the kind of operator with whom we do business," citing their successful medical cannabis licensing campaigns in New Hampshire, Massachusetts and Maryland. DeMena said both organizations are growing in markets across the country with an outsized demand for truly medical cannabis products.
MMS transdermal patch production has begun with clients in NH, MA and CA, and uses its proprietary MannaBot One ("MB1") to repeatably and accurately formulate patches. MB1 empowers even smaller-scale operators to grow rapidly without sacrificing quality or consistency, and allows operators to (1) manufacture transdermal patches on-demand, (2) scale the dose up or down, or (3) adjust cannabinoid ratios depending on patient needs, all with a software-enabled, easily-operated desktop unit.
MMS does not handle cannabis, but instead provides an installation kit that allows licensed operators to create its expertly designed transdermal patches on site. MMS was founded by a cannabis testing lab operator, an operations expert, and an MIT Ph.D. formulation chemist, and its product development team includes eminent transdermal expert Dr. Ken Miller, and a DMPK expert from Genzyme. MMS continues to attract new talent to its product and sales teams, and is expanding its portfolio with best-in-class infused products, technologies and delivery forms.
Temescal Wellness invests in, launches and manages state-legal cannabis companies. Founded in 2015, Temescal operates two dispensaries and an all-organic, cultivation-and-manufacturing facility in New Hampshire; is launching three dispensaries and an all-organic, cultivation-and-manufacturing facility in Massachusetts; and is building-out grower and processor licenses in Maryland. While expanding into new markets, Temescal is actively building its team of employees and its suite of investors to finance its growth.
Temescal Wellness of Maryland won one of fifteen grower licenses and one of fifteen processor licenses in August 2016. Temescal is pleased to invest in Baltimore City with its cultivation-and-manufacturing facility and anticipates serving qualifying Maryland patients beginning in late 2017. Temescal will bring to Maryland its dedication to patient wellness, product quality and community, including living-wage jobs, benefits and growth potential.
For more information:
Last updated on: 22/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.